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1356Objective: Postoperative acute kidney injury (AKI) after cardiopulmonary bypass (CPB) with coronary artery
bypass grafting is common and increases patient morbidity and mortality. Studies have identified the lowest
hematocrit during CPB, preoperative anemia, and intraoperative transfusion as modifiable AKI risk
factors. Because Asians are smaller in body size, the use of standard CPB circuits can result in excessive hemo-
dilution and subsequent transfusion to maintain the desired hematocrit target of 21% during CPB. Thus,
we aimed to ascertain whether the lowest hematocrit during CPB, preoperative anemia, and intraoperative
transfusion remained as independent modifiable risk factors associated with AKI in our prospective cohort of
Asians.
Methods: Data from 1448 patients who had undergone coronary artery bypass grafting with CPB from
December 2008 to December 2010 at Singapore’s 2 national heart centers were obtained. The perioperative
risk factors were analyzed for their associations with postoperative AKI. AKI was defined using the Acute
Kidney Injury Network stage 1 criteria.
Results: The incidence of AKI was 27.0% and mean lowest hematocrit during CPB was 24.5%  3.8%. The
risk of AKI increased with a decreasing lowest hematocrit during CPB (relative risk, 0.933; 95% confidence
interval, 0.899-0.968; P<.001), in particular with the lowest hematocrit of 22%. A 23% increased risk of
AKI was found for preoperative anemia (relative risk, 1.225; 95% confidence interval, 1.022-1.468;
P ¼ .028). Intraoperative transfusion was related on univariate analysis (P<.001) but was not independently
associated on multivariate analysis (relative risk, 0.961; 95% confidence interval, 0.782-1.180; P ¼ .702).
Conclusions: The lowest hematocrit and preoperative anemia were potentially modifiable risk factors indepen-
dently associated with AKI after cardiac surgery in our Asian population. Blood transfusion did not affect the
development of AKI in our population. (J Thorac Cardiovasc Surg 2014;147:1356-61)Postoperative acute kidney injury (AKI) after coronary
artery bypass grafting (CABG) with cardiopulmonary
bypass (CPB) is common and increases patient morbidity
and mortality.1,2 The perioperative risk factors for AKI
include patient age, history of diabetes, intra-aortic balloon
pump use, and CPB duration. Factors, such as the lowest he-
matocrit during CPB, intraoperative red blood cell (RBC)
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The Journal of Thoracic and Cardiovascular Suras independent modifiable risk factors that could contribute
to postoperative AKI.3-8
The lowest acceptable hematocrit during CPB has not
been definitively identified. However, it is generally agreed
that a hematocrit of 21% during CPB decreases renal
complications.4,9 The current practice has been to
maintain the hematocrit at or >21% during CPB. This
can require blood transfusion. However, the transfusion of
blood to ameliorate the effects of hemodilution can
increase the risk of AKI.3,4,6
Preoperative anemia has been identified to be the single
most important determinant of intraoperative blood transfu-
sion.10 Karkouti and colleagues11 have shown that anemic
patients are most likely to require multiple blood transfu-
sions during cardiac surgery and are also most likely to be
harmed by them. Preoperative anemia has therefore been
shown to increase the risk of AKI.6,7
Our patient population was predominantly Asian, who are
typically shorter and lighter than ourWestern counterparts.12
Using Nadler’s formula, the total blood volume is related to
the cubed product of the height and directly to the weight.13
Therefore, far greater hemodilution can occur in our patients
from the fixed amount of blood-free prime in theCPBcircuit,
resulting in a lower hematocrit during CPB. This cangery c April 2014
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AKI ¼ acute kidney injury
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
RBC ¼ red blood cell
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Ng et al Perioperative Managementnecessitate a greater rate of intraoperative transfusion to
conform to the hematocrit target, often requiring transfu-
sions even for patients who were not anemic preoperatively.
We postulated that the smaller body sizes of our patients
would compound the effect of preoperative anemia and in-
crease the rate of transfusion, leading to postoperative AKI.
We therefore embarked on the present study to determine
the incidence of AKI after CPB in our patient population
and to study the effect of known modifiable risk factors
(ie, lowest hematocrit during CPB, preoperative anemia,
and RBC transfusion) on the incidence of AKI after CABG.P
MMETHODS
Study Design, Database, and Population Selection
With institutional review board approval, we prospectively followed up
1744 Asian patients who had undergone primary, isolated CABG from
December 2008 to October 2011 at Singapore’s 2 national heart centers
(National University Health System and Singapore General Hospital).
All patients provided written informed consent. The perioperative variables
were collated and maintained in a cardiac database with regular audits. A
total of 296 patients were excluded from the present study because they
had had preoperative renal impairment (n¼ 237), had missing preoperative
and postoperative creatinine values (n ¼ 25), or undergone off-pump sur-
gery (n ¼ 34). The total number of patients who met the inclusion and
exclusion criteria was 1448. The normal creatinine range provided by
our laboratories was 60 to 105 mmol/L for men and 40 to 75 mmol/L for
women. Renal impairment was defined as serum creatinine>10 mmol/L
greater than normal and/or dialysis. This corresponded to the cutoff values
of serum creatinine of 115 mmol/L and 90 mmol/L that have been validated
in men and women, respectively, in screening for early renal impairment.14
Renal Function Assessment and Perioperative Renal
Data
The preoperative serum creatinine value usedwas that obtained closest to
surgery, typically at preadmission testing within 1 week of surgery. If a ma-
terial change had occurred in the patient’s condition, the serum creatinine
measurementwould be repeated the day before surgery, and that valuewould
be taken as the preoperative serumcreatinine. The peak serumcreatininewas
the highest creatinine value obtained within the first 3 postoperative days.
Stage I of the Acute Kidney Injury Network criteria was used as the primary
outcome, defined as an absolute increase in serum creatinine of 26.4
mmol/L and/or a 50% increase in the serum creatinine to the peak serum
creatinine from the preoperative serumcreatinine. The creatinine levels typi-
cally peaked on postoperative day 2 and had returned to baseline by day 5.15
Hematocrit, Hemodynamic, and Transfusion Data
The hematocrit was measured at heparinization and every 20 minutes
during CPB. Testing was performed using the routine arterial blood gasThe Journal of Thoracic and Caranalysis protocols on the Siemens RAPIDlab 1265 (Siemens Healthcare
Diagnostics, Tarrytown, NY). Blood transfusion was given to maintain a
hematocrit of21% during CPB and was guided by institutional protocol.
Preoperative Anemia Data
Preoperative anemia was defined according to the World Health Orga-
nization’s gender-based definition of<12.0 g/dL for women and<13.0
g/dL in men.
Perioperative Anesthesia and Surgical and Perfusion
Management
The perioperative surgical management and clinical practices at both
institutions were similar and followed international practice. Typically,
anesthesia was induced with intravenous induction agents (etomidate or
propofol) and maintained with a balanced anesthesia regimen of low-
dose fentanyl (10-20 mg/kg) and volatile agents (primarily sevoflurane).
Conventional CPB circuits with roller pumps, membrane oxygenators,
heat exchangers, venous reservoirs, cardiotomy suction, and arterial blood
filters were used. The volume of prime used in the CPB circuits was
typically 1300 to 1400 mL. The perfusion targets were mild-to-moderate
hypothermia (32-35C), hematocrit levels of21%, an activated clotting
time of>400 seconds, a glucose level of<10 mmol/L, a nonpulsatile flow
rate of 2.2 to 2.4 L/min/m2, and mean arterial pressure of 50 to 70 mm Hg.
Myocardial protection was achieved with cold blood cardioplegia.
Aprotinin was not used in any of the patients.
Statistical Analysis
Population demographics, medical history, preoperative risk assess-
ment, intraoperative variables, and postoperative outcomes were analyzed
descriptively. Univariate analysis was performed using a 2-tailed unpaired t
test or Mann-Whitney U test for numerical factors after normality assump-
tion was checked. The chi-square test was performed for categorical factors
on univariate analysis. The factors from the univariate analysis with P<.1
were included in the multivariate model. Multivariate analysis was per-
formed using the Poisson regression model with robust estimator to esti-
mate the adjusted relative risk (RR) of developing AKI after CPB for
CABG patients. The interaction effect between the lowest hematocrit dur-
ing CPB and the use of transfusion and the presence of preoperative anemia
was checked. Only the main effects would be included in the model if no
significant interaction was present. Collinearity among the factors was
also checked. All statistical analyses were performed using IBM SPSS,
version 20.0 (IBM, Armonk, NY). The data were plotted and logarithmic
trend lines drawn using Microsoft Excel 2010 (Microsoft, Redmond,
Wash).
RESULTS
A total of 1744 Asian patients underwent CABG during
the study period. Of these, 1448 patients met the inclusion
and exclusion criteria for our study. Of the 1448 patients,
391 developed AKI postoperatively. These patients were
more likely to be older and to have a history of diabetes
and hypertension. Other risk factors included preoperative
anemia, high preoperative creatinine, poor heart function,
the use of loop diuretics, urgent or emergent CABG surgery,
intra-aortic balloon pump use, a lower European System for
Cardiac Operative Risk Evaluation (EuroSCORE) logistic
score, longer CPB time, longer aortic crossclamp time,
and greater number of vein grafts harvested. They were
also more likely to have a lower lowest hematocrit during
CPB and to have received RBC transfusion (Table 1).diovascular Surgery c Volume 147, Number 4 1357
TABLE 1. Univariate analysis of perioperative risk factors associated
with AKI
Variable
AKI
(n ¼ 391)
No AKI
(n ¼ 1057) P value
Preoperative
Age (y) 61.7  9.4 58.7  8.9 <.001
Male gender 326 (83.4) 897 (84.9) .488
Body mass index (kg/m2) 25.6  4.2 25.1  3.7 .039
History of diabetes mellitus 219 (56.0) 517 (48.9) .016
History of hypertension 337 (86.2) 810 (76.6) <.001
Preoperative anemia 145 (37.1) 239 (22.6) <.001
Preoperative creatinine
(mmol/L)
91 (30) 83 (25) <.001
Loop diuretic medication 67 (17.1) 114 (10.8) .001
LVEF<30% 48 (12.3) 76 (7.2) .002
Urgent or emergent surgery 62 (15.9) 111 (10.5) .005
Use of IABP 79 (20.2) 96 (9.1) <.001
Logistic EuroSCORE 4.0  4.7 2.9  3.3 <.001
Intraoperative
Lowest hematocrit during
CPB (%)
23.3  3.6 24.9  3.8 <.001
RBC transfusion 167 (42.7) 275 (26.0) <.001
CPB time (min) 128  77.6 105.3  42.1 <.001
Aortic crossclamp time (min) 69.3  40.4 62.6  32.6 .002
Vein grafts harvested (n) 3.1  0.8 3  1 .038
Use of left internal mammary
artery
380 (97.2) 1014 (96.1) .330
Data presented as n (%) or mean  standard deviation. AKI, Acute kidney
injury; LVEF, left ventricular ejection fraction; IABP, intra-aortic balloon pump;
RBC, red blood cell; CPB, cardiopulmonary bypass; EuroSCORE, European System
for Cardiac Operative Risk Evaluation.
FIGURE 1. Acute kidney injury (AKI) incidence against lowest hemato-
crit during cardiopulmonary bypass (CPB) for study cohort with logarith-
mic trend line.
FIGURE 2. Acute kidney injury (AKI) incidence against lowest hemato-
crit during cardiopulmonary bypass (CPB) for transfused and nontrans-
fused patients in study cohort with logarithmic trend lines. RR, Relative
risk; CI, confidence interval.
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MLowest Hematocrit During CPB
The mean lowest hematocrit for the whole cohort was
24.5%  3.8% (range, 14%-47%). The lowest hematocrit
was<21% in 192 patients (13.3% of the study population).
These patients had an AKI incidence of 46.4% versus
24.0% for those whose hematocrit during CPB was
21% (P<.001). After adjusting for other statistically sig-
nificant factors, the lowest hematocrit during CPB was
independently associated with AKI (RR, 0.933; 95% confi-
dence interval [CI], 0.899-0.968; P<.001). The incidence
of AKI increased with a decreasing lowest hematocrit dur-
ing CPB, in particular, with the lowest hematocrit of22%
(Figure 1).
Preoperative Anemia
A total of 384 patients (26.5% of study population) had
preoperative anemia, and 37.8% of these patients devel-
oped AKI. Preoperative anemia was also found to be
independently associated with AKI (RR, 1.225; 95% CI,
1.022-1.468, P ¼ .028). The presence of preoperative ane-
mia incurred a 23% increased risk of AKI. The mean lowest
hematocrit during CPB differed significantly between those
with preoperative anemia who did and did not develop AKI
(21.6%  2.6% vs 22.6%  2.8%; P ¼ .001).1358 The Journal of Thoracic and Cardiovascular SurIntraoperative Transfusion
A total of 501 patients met the transfusion guidelines.
However, only 442 patients (30.5% of study population)
underwent transfusion. Of these 442 patients, 43.5% devel-
oped AKI. The age of the RBCs used for transfusion was
10.7  7.8 days. Transfusion was, however, not indepen-
dently associated with the development of AKI in our study
(RR, 0.961; 95% CI, 0.782-1.180; P ¼ .702; Figure 2).Other Factors
The other factors that increased the risk of developing
AKI included older patient age (70 years; RR, 1.350;
95% CI, 1.085-1.679; P ¼ .007), larger body mass index
(RR, 1.053; 95% CI, 1.030-1.077; P<.001), history of hy-
pertension (RR, 1.355; 95% CI, 1.038-1.768; P ¼ .025),
higher preoperative creatinine value (RR, 1.003; 95% CI,
1.001-1.006; P ¼ .016), intra-aortic balloon pump use
(RR, 1.480; 95% CI, 1.184-1.895; P< .001), and longer
CPB time (RR, 1.003; 95% CI, 1.002-1.004; P< .001;
Table 2).gery c April 2014
TABLE 2. Multivariate analysis of perioperative risk factors
associated with AKI
Variable RR 95% CI P value
Preoperative
Age (70 y) 1.350 1.085-1.679 .007
Body mass index (kg/m2) 1.053 1.030-1.077 <.001
History of diabetes mellitus 1.074 0.897-1.285 .438
History of hypertension 1.355 1.038-1.768 .025
Preoperative anemia 1.225 1.022-1.468 .028
Preoperative creatinine (mmol/L) 1.003 1.001-1.006 .016
Loop diuretic medication 1.203 0.960-1.506 .108
LVEF<30% 1.162 0.886-1.523 .278
Urgent or emergent surgery 1.094 0.866-1.383 .450
Use of IABP 1.480 1.184-1.851 <.001
Logistic EuroSCORE 1.002 0.988-1.017 .752
Intraoperative
Lowest hematocrit during CPB (%) 0.933 0.899-0.968 <.001
RBC transfusion 0.961 0.782-1.180 .702
CPB time (min) 1.003 1.002-1.004 <.001
Aortic crossclamp time (min) 1.000 0.9998-1.002 .906
Vein grafts harvested (n) 1.049 0.963-1.143 .272
AKI, Acute kidney injury; RR, relative risk; CI, confidence interval; LVEF, left
ventricular ejection fraction; IABP, intra-aortic balloon pump;CPB, cardiopulmonary
bypass; RBC, red blood cell; EuroSCORE, European System for Cardiac Operative
Risk Evaluation.
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Of the 391 patients who developed AKI, 19 (4.9% of the
AKI population) developed a new need for dialysis after
CABG. Of these 19 patients, 5 subsequently died (mortality
26.3%).DISCUSSION
The incidence of AKI in our study was 27.0%. This was
at the higher end of the range (1%-30%) in published
studies from Europe and North America.1,2 The lowest
hematocrit and preoperative anemia were both
independent factors for the development of post-CPB AKI.P
MLowest Hematocrit and AKI Incidence
The lowest hematocrit during CPB is a reliable indicator
of the degree of hemodilution. The kidneys are vulnerable
to changes in renal blood flow because their metabolism
is flow-dependent.9 However, hemodilution increases kid-
ney perfusion, but it also causes an increase in the energy
requirement of kidneys because of increased tubular trans-
port. This, coupled with the decreased oxygen delivery
due to hemodilution and the physiologic hypoxic environ-
ment of the renal medulla, can precipitate AKI injury, espe-
cially in the oxygen-sensitive renal medulla.2,5
In our study, the lowest hematocrit during CPB was iden-
tified as 1 of the potentially modifiable risk factors for our
Asian patients undergoing CABG surgery. The lowest he-
matocrit during CPB in our patient population of 24.5%
 3.8% corroborated with that of previous studies.4,5,9The Journal of Thoracic and CarThe incidence of AKI in our cohort increased with a
decreasing lowest hematocrit during CPB. It was at the
lowest hematocrit of 22% at which the AKI incidence
increased more dramatically (Figure 1). Our findings were
in agreement with published studies that have shown the as-
sociation of lowest hematocrit during CPB with poorer
renal outcomes.4,9 Habib and colleagues4 showed that the
renal failure rates increased as the lowest hematocrit during
CPB decreased, in particular when the lowest hematocrit
value was<22%. Karkouti and colleagues9 showed that
when the lowest hematocrit during CPB was<21%, the
odds of developing acute renal failure with the need for dial-
ysis was 2.34 times greater than when lowest hematocrit
during CPB was maintained at 21% to 25%.
Themeanbodymass index inour cohortwas 25.2 3.8 kg/
m2. Western studies have reported that the mean body mass
index of their patients ranged from 28.2 to 29.2.16,17
Because Asians are smaller in body size, the use of standard
CPB circuits designed for Western populations could have
resulted in greater hemodilution. However, the lowest
hematocrit values during CPB ranged from 14% to 47% in
our study, similar to that reported by other studies.4,9 This
was likely because of the liberal use of blood transfusion
during CPB to keep an hematocrit of 21% in our practice.
Preoperative Anemia and AKI Incidence
Anemia contributes to AKI by the reduction of renal
oxygen delivery and impaired hemostasis.6 Coupled with
the increased risk of bleeding because of CPB-related he-
mostatic defects, anemia-induced platelet dysfunction can
lead to excessive bleeding during cardiac surgery. This, in
turn, will necessitate a greater rate of transfusion, further
aggravating the risk of AKI.6
In our study, preoperative anemia has been identified as 1
of the potentially modifiable risk factors for our Asian pa-
tients undergoing CABG surgery. Preoperative anemia
increased the risk of AKI by 23%, corroborating the find-
ings of published studies.6,7,10 Asians with a smaller
body size and preoperative anemia will be particularly
prone to excessive hemodilution and subsequent blood
transfusion—a double insult that could explain the high
rate of blood transfusion and risk of AKI in this population.
The patients with preoperative anemia who developed
AKI had a mean lowest hematocrit of 21.6%  2.6%.
This is within the target hematocrit level during CPB and
suggests that the target level of hematocrit might well differ
between anemic and nonanemic patients in terms of
reducing the AKI risk.
Intraoperative Transfusion and AKI Incidence
Of our patients, 30.5% were transfused intraoperatively.
The transfusion rate was about 2 times greater than that
in other reported series.18,19 Transfusion was, however,
not independently associated with postoperative AKIdiovascular Surgery c Volume 147, Number 4 1359
Perioperative Management Ng et al
P
Mdevelopment in our study (RR, 0.961; 95% CI,
0.782-1.180; P ¼ .702). Transfusion did not play a role in
influencing AKI outcomes as significant as that for the
lowest hematocrit during CPB (Figure 2). This was surpris-
ing, because published data have shown that blood transfu-
sion during CPB in itself can contribute to the risk of AKI
by exacerbating the CPB-initiated systemic inflammatory
response syndrome with a second inflammatory response,
further contributing to ischemia–reperfusion injury in the
kidneys.20 It can be postulated that blood transfusion in
our population partially ameliorated the deleterious effects
of the low hematocrit during CPB. This has confirmed that
avoiding excessive hemodilution should be the primary
objective in the avoidance of postoperative AKI in Asian
patients undergoing CABG surgery with CPB, even if the
liberal use of transfusion is required.
The present study had several strengths. It was a prospec-
tive study with clearly defined data points. The study popu-
lation was relatively homogenous, because all patients had
easy access to subsidized healthcare. The present study was
protocol-driven, with uniform practice among the various
anesthetists, perfusionists, and surgeons, ensuring the reli-
ability of the data.
One of the limitations of the present study was that the
patients who needed intraoperative blood transfusion to
maintain a hematocrit of 21% were not differentiated.
These patients typically included those with a low body
weight or preoperative anemia. The former group of pa-
tients will be subjected to acute hemodilution and the latter
will already have compensatory mechanisms in place
because of the pre-existing anemia. The pathogeneses lead-
ing to AKI in these 2 groups of patients are likely to be
different.11 Future analyses to differentiate these 2 groups
of patients will lead to a better understanding of the
response of these patients to CPB-induced hemodilution
and the risk of AKI. This will allow modification of the
management during CPB using a dual strategy (eg, the
use of mini-CPB circuits21 for low body weight patients
and preoperative treatment of anemic patients using
agents such as erythropoietin22). Through such strategies,
2 potentially modifiable AKI risks could be significantly
reduced.
Another limitation of the present study was the lack of
data on the patients’ hydration status. Dehydration and fluid
overload can result in elevation or reduction of a patient’s
hematocrit, respectively. However, most of our patients
were hemodynamically stable and had undergone elective
isolated CABG. Thus, the lowest hematocrit during CPB
largely resulted from hemodilution effects or blood loss
during surgery and not the patient’s hydration status.
CONCLUSIONS
The lowest hematocrit during CPB and preoperative ane-
mia are 2 potentially modifiable independent risk factors1360 The Journal of Thoracic and Cardiovascular Surthat should be optimized to reduce the incidence of AKI
during cardiac surgery in the Asian population. Intraopera-
tive transfusion was not independently associated with post-
operative AKI development, and blood transfusion to
maintain the hematocrit at 21% appeared not to be dele-
terious. Our results indicate that treatment of preoperative
anemia and maintenance of a hematocrit of 21% should
be used as strategies to reduce the incidence of AKI after
CABG in the Asian population.References
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